Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Avadel Pharmaceuticals (AVDL – Research ...

Maze fits the mold of biotechs that have pulled off successful offerings recently: The seven-year old startup, which raised ...

Repirinast is the Company’s lead candidate for the treatment of CKD based on data showing it reduced fibrosis by 51% with statistical significance and showed an additive benefit to telmisartan in a ...